DrugPatentWatch Database Preview

Details for Patent: 8,128,960

Which drugs does patent 8,128,960 protect, and when does it expire?

Patent 8,128,960 protects TRIESENCE and is included in one NDA.

This patent has twenty patent family members in nineteen countries.

Summary for Patent: 8,128,960

Title:	Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
Abstract:	Triamcinolone acetonide suspension compositions are disclosed. The suspension compositions have a relatively low viscosity and are easy to extrude through a 27- or 30-gauge needle but are highly flocculated and easily redispersed. The compositions are particularly suitable for intravitreal injection.
Inventor(s):	Kabra; Bhagwati P. (Euless, TX), Sarkar; Ruma (Fort Worth, TX)
Assignee:	Alcon Research, Ltd. (Fort Worth, TX)
Application Number:	12/401,168
Patent Claim Types: see list of patent claims	Composition; Compound; Formulation;

Drugs Protected by US Patent 8,128,960

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Novartis Pharms Corp	TRIESENCE	triamcinolone acetonide	INJECTABLE;INTRAVITREAL	022048-001	Nov 29, 2007		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Non-Orange Book US Patents Family Members for Patent 8,128,960

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
8,211,880	Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Family Members for US Patent 8,128,960

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Taiwan	I468165	➤ Sign Up
Taiwan	200940071	➤ Sign Up
Slovenia	2262506	➤ Sign Up
Russian Federation	2481842	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 8,128,960

For more information try a trial or see the plans and pricing